Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.
about
Anti-TNF agents for paediatric psoriasisAnti-TNF agents for paediatric psoriasisOpposing activities of two novel members of the IL-1 ligand family regulate skin inflammationEmerging drugs for moderate-to-severe psoriasis.A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis.Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin.Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin.The role of T cells in cutaneous autoimmune disease.Infliximab for the treatment of psoriasis.Dendritic cells and cytokines in human inflammatory and autoimmune diseasesDrug focus: adalimumab in the treatment of moderate to severe psoriasis.Immunomodulatory and anti-inflammatory effects of chondroitin sulphate.A case of concurrent vitiligo and psoriasisAnti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis.Influence of infliximab on keratinocyte apoptosis in psoriasis patients.Topical isoflavonoids reduce experimental cutaneous inflammation in mice.Analysis of the levels of tumour necrosis factor (TNF), autoantibodies to TNF, and soluble TNF receptors in patients with rheumatoid arthritis.Psoriasis and lasting implications.Serious infections among a large cohort of subjects with systemically treated psoriasis.Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.Synthesis and evaluation of a tag-free photoactive phospho-ceramide analogue-1 (PCERA-1) probe to study immunomodulation in macrophages.Does MBL2 codon 54 polymorphism play a role in the pathogenesis of psoriasis?Effective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions
P2860
Q24187673-55D6F29D-CC9E-49B9-A179-2D4C9AD08ECCQ24201907-B016E14B-E3BB-49A9-8BCC-770CA660DCA1Q24676343-87999852-04ED-4B40-A28C-CE0F3B3F7352Q30984470-6A82A58F-ECEF-4D21-A543-B9AC58DB8EE5Q33530087-4EFCBA03-59D4-40F9-9A53-00DF45814F3CQ35109173-023551F6-E664-469B-8D45-4D6AA2E7BF30Q36094366-2CEB76D9-BA0E-4666-B82C-EBEDB8A70529Q36277428-2D972208-B3ED-4CAF-9B3D-7BE4A4FDCA5CQ36541961-4A0AB265-E0B5-4FAE-9B4B-1825BCC7440CQ36699918-D645CA96-AE46-4727-870F-42AF714ED3B8Q37290478-DCF6DF98-3C2C-49BC-9527-94190625885AQ37310621-846061EA-F15C-4D3C-ACB5-CC2E888A36F5Q37762734-8DF784B3-506A-4437-8990-354C08263297Q37810960-E5914D41-8D7C-4B97-9085-BE221489FD01Q37945301-5BA458C4-F2FB-4FB2-8795-ACFEA63A0EFFQ38582187-12C37C7B-B805-4BFD-B40E-7E51E6F46A93Q38611360-4C0E7ABD-8300-417F-96D4-5B3DFBA58E54Q38799600-F80F786B-93AC-4DDC-96FB-014C86D8C948Q39276466-1B956A91-E108-4F6C-B725-2E4849672BBFQ39570426-A4994723-F8DF-45BF-BC93-358E94053044Q42472143-3EAAF934-756D-4631-B361-AB537C10B03CQ43138001-0BCC2F7E-30EF-4707-9C21-B0A711EF0C5AQ45965393-2FD1C158-19F0-454A-B176-7F1A432B3701Q46138558-02B2F5AD-1D66-49D5-98C0-378463BA5F8CQ46731189-728000CE-5B7E-49ED-AA47-06C6A59BCDE1Q46975812-24079D57-181C-4E85-8FC3-D196F41672BEQ48106607-6001D818-F054-4BB5-B22E-3F68BBF9EB21Q54285327-467C4656-4CAE-47F9-B90F-7F33294BE4C1Q59154938-53EC0765-729B-427C-94DE-681F2EB79EE6
P2860
Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@ast
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@en
type
label
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@ast
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@en
prefLabel
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@ast
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@en
P2093
P1476
Changing paradigms in dermatol ...... iasis and psoriatic arthritis.
@en
P2093
Alan Menter
Alice B Gottlieb
Frank C Victor
P304
P356
10.1016/J.CLINDERMATOL.2003.08.015
P577
2003-09-01T00:00:00Z